Hanmi Pharm. Co., Ltd. Disclosures

128940 · KOSPI · Based on DART filings

Disclosures

1 major

Newest first

Oct 27, 2026 4:07 PMMajor

20261027800461

Hanmi Pharmaceutical's 3Q 2026 consolidated revenue was KRW 377.4 billion, up 4.2% year over year but down 19.2% quarter over quarter; operating profit was KRW 37.8 billion, down 31.3% and 71.2%.

Catch the next disclosure fast

Get app alerts for new disclosures from Hanmi Pharm. Co., Ltd..